Presentation is loading. Please wait.

Presentation is loading. Please wait.

Flowchart of the process of study selection LAR indicates laboratory-defined aspirin resistance Jaapjan D. Snoep, et al. Arch Intern Med 2007;167:1593-9.

Published byHartono Lesmana Modified over 5 years ago

Similar presentations

Presentation on theme: "Flowchart of the process of study selection LAR indicates laboratory-defined aspirin resistance Jaapjan D. Snoep, et al. Arch Intern Med 2007;167:1593-9."— Presentation transcript:

1 Flowchart of the process of study selection LAR indicates laboratory-defined aspirin resistance
Jaapjan D. Snoep, et al. Arch Intern Med 2007;167:1593-9

2 Details of Included Studies – Part I
Jaapjan D. Snoep, et al. Arch Intern Med 2007;167:1593-9

3 Details of Included Studies – Part II
Jaapjan D. Snoep, et al. Arch Intern Med 2007;167:1593-9

4 Details of Included Studies – References
Jaapjan D. Snoep, et al. Arch Intern Med 2007;167:1593-9

5 Statistical Details of Included Studies
Jaapjan D. Snoep, et al. Arch Intern Med 2007;167:1593-9

6 Forest plots of odds ratios (ORs) of the cardiovascular outcome for patients with LAR vs those without LAR from eligible studies Jaapjan D. Snoep, et al. Arch Intern Med 2007;167:1593-9

Download ppt "Flowchart of the process of study selection LAR indicates laboratory-defined aspirin resistance Jaapjan D. Snoep, et al. Arch Intern Med 2007;167:1593-9."

Similar presentations

(a) (b) (c) (d). What is (1,2,3)  (3,4,2)? (a) (1, 2, 3, 4) (b) (1,2)  (3,4) (c) (1,3,4,2) (d) (3,1)  (4,2)

(a) (b) (c) (d). What is (1,2,3)  (3,4,2)? (a) (1, 2, 3, 4) (b) (1,2)  (3,4) (c) (1,3,4,2) (d) (3,1)  (4,2)
Solomon Tesfaye et al N Engl J Med 2005;352:341- 50 Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.

Solomon Tesfaye et al N Engl J Med 2005;352: Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.
Literature Appraisal Effectiveness of Therapy. Measures of treatment effect Statistical significance Odds ratio Relative risk Absolute risk reduction.

Literature Appraisal Effectiveness of Therapy. Measures of treatment effect Statistical significance Odds ratio Relative risk Absolute risk reduction.
Shalev V, et al. Arch Intern Med 2009; 169:260-268.

Shalev V, et al. Arch Intern Med 2009; 169:
Flow diagram of the systematic literature search indicating the inclusion and exclusion process of studies Liakopoulos OJ, et al. Eur Heart J 2008;29:1548-59.

Flow diagram of the systematic literature search indicating the inclusion and exclusion process of studies Liakopoulos OJ, et al. Eur Heart J 2008;29:
Flow diagram of study selection process CAB: Commonwealth Agricultural Bureau Ethan M. Balk, et al. Arch Intern Med. 2007;167:21-30.

Flow diagram of study selection process CAB: Commonwealth Agricultural Bureau Ethan M. Balk, et al. Arch Intern Med. 2007;167:21-30.
Flowchart of study participants MedDiet indicates Mediterranean diet; VOO, virgin olive oil Jordi Salas-Salvado, et al. Arch Intern Med 2008;168:2449-58.

Flowchart of study participants MedDiet indicates Mediterranean diet; VOO, virgin olive oil Jordi Salas-Salvado, et al. Arch Intern Med 2008;168:
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Use of Inhaled Corticosteroids and the Risk.

Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Use of Inhaled Corticosteroids and the Risk.
Date of download: 9/16/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Cranberry-Containing Products for Prevention of Urinary.

Date of download: 9/16/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Cranberry-Containing Products for Prevention of Urinary.
Copyright © 2016 American Medical Association. All rights reserved.

Copyright © 2016 American Medical Association. All rights reserved.
(p for noninferiority = 0.01)

(p for noninferiority = 0.01)
Copyright © 2005 American Medical Association. All rights reserved.

Copyright © 2005 American Medical Association. All rights reserved.
Copyright © 2012 American Medical Association. All rights reserved.

Copyright © 2012 American Medical Association. All rights reserved.
Arch Intern Med. 2007;167(1): doi: /archinte Figure Legend:

Arch Intern Med. 2007;167(1): doi: /archinte Figure Legend:
Flowchart of participants

Flowchart of participants
Local Breast Cancer Recurrence after Mastectomy and Breast-Conserving Surgery for Paget's Disease: A Meta-Analysis Breast Care 2014;9:431-434 - DOI:10.1159/000368431.

Local Breast Cancer Recurrence after Mastectomy and Breast-Conserving Surgery for Paget's Disease: A Meta-Analysis Breast Care 2014;9: DOI: /
Flowchart of participant screening, enrollment, withdrawal, and protocol completion Asterisk indicates those with partial or missing data included in analyses.

Flowchart of participant screening, enrollment, withdrawal, and protocol completion Asterisk indicates those with partial or missing data included in analyses.
Copyright © 2012 American Medical Association. All rights reserved.

Copyright © 2012 American Medical Association. All rights reserved.
SOCRATES Trial design: Patients with acute ischemic stroke were randomized in a 1:1 fashion to receive either ticagrelor 180 mg load + 90 mg BID or aspirin.

SOCRATES Trial design: Patients with acute ischemic stroke were randomized in a 1:1 fashion to receive either ticagrelor 180 mg load + 90 mg BID or aspirin.
Markov model structure

Markov model structure

Similar presentations

Ads by Google